Biopharma Co.'s Down-Round IPO May Signal More To Come
Biotech Eikon Therapeutics is preparing for a down-round IPO experts say may serve as a bellwether for how certain life sciences companies get valued in public markets.
Legal Risks Complicate Drugmakers' TrumpRx Participation
Federal watchdog guidance on the soon-to-be-launched TrumpRx website has assuaged some, but not all, concerns about anti-kickback compliance and other legal risks facing drugmakers.
Biotech Fundraising A Good Sign For Public Markets
At the start of what many healthcare attorneys hope will be a busy year, public biotechs are raising cash, signaling a thawing public market and potentially fertile ground for IPOs.
Biopharma Co.'s Down-Round IPO May Signal More To Come
Biotech Eikon Therapeutics is preparing for a down-round IPO experts say may serve as a bellwether for how certain life sciences companies get valued in public markets.
Legal Risks Complicate Drugmakers' TrumpRx Participation
Federal watchdog guidance on the soon-to-be-launched TrumpRx website has assuaged some, but not all, concerns about anti-kickback compliance and other legal risks facing drugmakers.
Biotech Fundraising A Good Sign For Public Markets
At the start of what many healthcare attorneys hope will be a busy year, public biotechs are raising cash, signaling a thawing public market and potentially fertile ground for IPOs.
Expert Analysis
In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice ad... (more story)
.jpg)
With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Depar... (more story)
Texas Attorney General Ken Paxton has targeted technology companies using the Texas Deceptive Trade Practices Act,... (more story)
Deals & Corporate Governance More
Pharmaceutical giant Eli Lilly & Co., advised by Paul Weiss Rifkind Wharton & Garrison LLP, on Monday announced that it has agreed to buy Goodwin Procter LLP-led biotechnology firm Orna Therapeutics Inc. in a ... (more story)
U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo ... (more story)
A Colorado healthcare nonprofit Thursday voluntarily dismissed its complaint seeking to reverse an allegedly unlawful executive order signed by Gov. Jared Polis that cut state Medicaid spending to pediatric be... (more story)
The U.S. Securities and Exchange Commission is suing a Kentucky pharmaceutical company for securities fraud based on claims that the company raised $4.1 million by lying to investors about the status of its ca... (more story)
A New Jersey federal judge has refused to disturb a magistrate judge's decision compelling a state watchdog to turn over documents from its inquiry into CarePoint Health Systems Inc., rejecting the agency's bi... (more story)
A New York anesthesiology practice didn't sustain an antitrust injury when a UnitedHealthcare unit used its market power to cut reimbursement rates, a Second Circuit panel affirmed Friday, finding that the cha... (more story)
Digital Health & Technology More
The Federal Circuit on Monday reversed a lower court's ruling that Abiomed Inc. hasn't infringed five patents on blood pump systems and methods, while backing the part of the decision that cleared the medical ... (more story)
Novo Nordisk AS followed through on Monday in Delaware federal court on a plan it announced last week to sue telehealth company Hims & Hers Health Inc. over its marketing of what Novo Nordisk calls a knockoff ... (more story)
A data science platform and its top brass persuaded its former chief strategy officer and president to invest $750,000 in the business, only then to not pay him wages, the former employee told a North Carolina... (more story)
A Massachusetts federal judge awarded Insulet Corp.'s attorneys almost $15 million for their $452 million jury trial victory in a trade secrets dispute that was later reduced to $59.4 million, but the fees Goo... (more story)
A private healthcare data analytics company on Wednesday urged a Michigan federal court to dismiss a consolidated proposed class action stemming from a cyberattack, arguing the patients' claims rest on specula... (more story)
Utah recently became the first state to approve an artificial intelligence system for autonomously renewing certain prescription medicines, providing a test case for how regulators may be able to draw boundari... (more story)
Policy & Compliance More
Medical supply giant AdaptHealth Corp. has tentatively settled an overbilling suit brought by a proposed class of patients who claim they were overcharged for home healthcare equipment, according to a North Ca... (more story)
A Georgia appeals court backed a win for sperm bank Xytex Corp. in consolidated litigation alleging the company sold sperm under false pretenses about the medical, psychological and social history of the donors.
D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt bu... (more story)
An Arizona state court permanently struck down a slew of restrictions on abortion care in the state, including an ultrasound mandate and a ban on the mailing of abortion pills, finding the restrictions violate... (more story)
A Cambridge hospital system agreed to pay $595,000 to settle a proposed class action claiming it mismanaged its $280 million retirement plan and cost workers millions in savings by failing to reduce management... (more story)
The U.S. Department of Health and Human Services has ended a proposed rebate program that would have altered how hospitals receive payments for participating in the federal 340B drug discount program, which pr... (more story)